Clinical Trials
4
Active:3
Completed:0
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 2
1 (25.0%)phase_2_3
1 (25.0%)Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain
Phase 2
Active, not recruiting
- Conditions
- Osteoarthritis, Knee
- Interventions
- Drug: Placebo (Sodium Chloride Injection, 0.9%)Drug: Pentosan Polysulfate Sodium twice weeklyDrug: Pentosan Polysulfate Sodium once weeklyDrug: Pentosan Polysulfate Sodium Fixed Dose
- First Posted Date
- 2021-03-22
- Last Posted Date
- 2024-04-08
- Lead Sponsor
- Paradigm Biopharmaceuticals USA (INC)
- Target Recruit Count
- 602
- Registration Number
- NCT04809376
- Locations
- 🇺🇸
Alliance for Multispecialty Research - Tempe, Tempe, Arizona, United States
🇺🇸Fiel Family and Sports Medicine, Tempe, Arizona, United States
🇺🇸Tucson Orthopaedic Institute, Tucson, Arizona, United States
News
No news found